Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma

Abstract

Background and Purpose We recently reported a time-sensitive, cooperative, anti-tumor effect elicited by radiation (RT) and intra-tumoral-immunocytokine injection in vivo. We hypothesized that RT triggers transcriptional-mediated changes in tumor expression of immune susceptibility markers at delayed time points, which may explain these previously observed time-dependent effects. Materials and Methods We examined the time course of changes in expression of immune susceptibility markers following in vitro or in vivo RT in B78 murine melanoma and A375 human melanoma using flow cytometry, immunoblotting, and qPCR. Results Flow cytometry and immunoblot revealed time-dependent increases in expression of death receptors and T cell co-stimulatory/co-inhibitory ligands following RT in murine and human melanoma. Using high-throughput qPCR, we observed comparable time courses of RT-induced transcriptional upregulation for multiple immune susceptibility markers. We confirmed analogous changes in B78 tumors irradiated in vivo. We observed upregulated expression of DNA damage response markers days prior to changes in immune markers, whereas phosphorylation of the STAT1 transcription factor occurred concurrently with changes following RT. Conclusions This study highlights time-dependent, transcription-mediated changes in tumor immune susceptibility marker expression following RT. These findings may help in the design of strategies to optimize sequencing of RT and immunotherapy in translational and clinical studies.

Radiation Therapy Combined with Cowpea Mosaic Virus Nanoparticle in Situ Vaccination Initiates Immune-Mediated Tumor Regression

“… 21 , 28 Although activation of this pathway may initially lead to a cytotoxic T-cell-mediated antitumor response, IFN-mediated immune-suppressive pathways are also activated with recruitment of myeloid-derived suppressor cells, 29 regulatory T cells (Tregs), 30 and induction of tumor cell PDL1 expression. 31 …”

Prospective Immunophenotyping of CD8+ T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT

“…14,15 Time points were chosen to analyze PBMCs during the window of greatest presumed change in phenotypic expression, which was estimated to occur between 1–2 weeks post-SBRT. 16…”

The Promise of Combining Radiation Therapy With Immunotherapy

“…37 High-dose radiation also leads to dosedependent increases in the expression of MHC-1 and death receptors such as Fas, which are critical for T cell killing of tumor cells. 38,39 In contrast, moderate fractional doses of 8 to 12 Gy may be optimal for activating a type I interferon response in tumor cells via a dose-dependent increase in the cytoplasmic leakage of DNA from micronuclei, which activates the cGAS/STING pathway. 17,40 At higher doses, radiation-induced STING activation may decline in part because of induced expression of Trex1 exonuclease, which reduces the accumulation of cytoplasmic DNA, resulting in negative feedback inhibition.…”